Silence Therapeutics Plc ADR
(SLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,067 | -2,312 | -54,228 | -44,742 | -30,906 |
| Depreciation Amortization | 302 | 152 | 621 | 477 | 316 |
| Accounts receivable | -2,043 | -10,012 | 392 | 101 | -14,751 |
| Accounts payable and accrued liabilities | 3,003 | -2,849 | -473 | -903 | -1,010 |
| Other Working Capital | 610 | -10,323 | -15,244 | -13,329 | -17,780 |
| Other Operating Activity | 5,643 | 16,201 | 19,470 | 23,603 | 35,819 |
| Operating Cash Flow | $-14,552 | $-9,143 | $-49,462 | $-34,792 | $-28,313 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -49,908 | 45,121 | 19,643 | N/A |
| PPE Investments | -85 | N/A | -56 | -56 | -30 |
| Purchase Of Investment | -49,866 | N/A | -25,771 | N/A | 20,133 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -25,873 |
| Other Investing Activity | 0 | 0 | 0 | 728 | -25,837 |
| Investing Cash Flow | $-49,951 | $-49,908 | $19,294 | $20,315 | $-5,735 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 134,213 | 133,020 | 31,937 | 19,452 | 4,113 |
| Other Financing Activity | 0 | 0 | 0 | -166 | -103 |
| Financing Cash Flow | $134,213 | $133,020 | $31,937 | $19,286 | $4,011 |
| Exchange Rate Effect | -49 | -35 | 749 | 249 | -1,386 |
| Beginning Cash Position | 68,789 | 68,789 | 66,271 | 69,392 | 68,635 |
| End Cash Position | 138,450 | 142,723 | 68,789 | 74,450 | 37,212 |
| Net Cash Flow | $69,661 | $73,934 | $2,518 | $5,059 | $-31,423 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,552 | -9,143 | -49,462 | -34,792 | -28,313 |
| Capital Expenditure | -85 | N/A | -56 | -56 | -30 |
| Free Cash Flow | -14,637 | -9,143 | -49,518 | -34,848 | -28,343 |